v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (2,018,000) $ (1,147,000) $ 918,355 $ (3,270,544)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation 502,000 636,000    
Amortization of right of use assets 36,000    
Change in fair value of contingent consideration (3,972,000)    
Depreciation 28,000    
Amortization of intangibles 3,964,000    
Amortization of prepaid expenses 2,194,000    
Provision for expected credit losses 597,000    
Changes in operating assets and liabilities:        
Accounts receivable (82,085,000)    
Contract assets 2,908,000    
Contract assets, related party 2,634,000    
Prepaid expenses and other current assets 8,000 7,000    
Other receivable, related party 13,000    
Due to / from related party (110,000)      
Accounts payable 78,405,000    
Accounts payable, related party (5,578,000) 72,000    
Accrued expenses and other current liabilities 938,000 (49,000)    
Contract liabilities 17,000    
Deferred tax liability 0    
Operating lease liabilities, net (36,000)    
Net cash used in operating activities (1,555,000) (481,000) (1,487,560)  
Cash flows from investing activities:        
Purchase of property, plant and equipment (12,000)    
Software development capitalization (162,000)    
Net cash used in investing activities (174,000)    
Cash flows from financing activities:        
Short-term advances 295,000    
Repayment of loan    
Accounts receivable financing facility 4,784,000    
Proceeds from sale of common stock 220,000 85,000    
Net cash provided by financing activities 5,004,000 380,000    
Effect of exchange rate changes on cash and cash equivalents (95,000)    
Net change in cash and cash equivalents 3,180,000 (101,000)    
Cash and cash equivalents and restricted cash at beginning of period 2,108,000 107,000 107,000  
Cash and cash equivalents and restricted cash at end of period 5,288,000 6,000 2,108,000 107,000
Reconciliation of cash and restricted cash:        
Cash at beginning of period 2,087,000 107,000 107,000  
Restricted cash at beginning of period 21,000  
Cash and restricted cash at beginning of period 2,108,000 107,000 107,000  
Cash at end of period 5,267,000 6,000 2,087,000 107,000
Restricted cash at end of period 21,000 21,000
Cash and restricted cash at end of period 5,288,000 6,000 2,108,000 107,000
Supplemental disclosure of cash flow information:        
Cash paid for income taxes    
Cash paid for interest 885,000    
Non-cash investing and financing activities:        
Purchase of intangible assets in exchange of issuance of common stock     19,710,000  
Issuance of common stock pursuant to business combination     12,880,000  
Common stock to be issued pursuant to business combination     3,407,250  
Settlement of related party liabilities 676,000    
Common stock issued in settlement of earn-out contingent consideration 14,474,000    
Previously Reported        
Cash flows from operating activities:        
Net loss     918,355 (3,270,544)
Adjustments to reconcile net loss to net cash used in operating activities:        
Bad debt     12,995  
Stock-based compensation     1,077,319 1,165,151
Common stock issued for professional and marketing services     350,224
Amortization of right of use assets     23,320
Change in fair value of contingent consideration     (3,387,266)
Depreciation     26,302
Amortization of intangibles     1,572,441
Deferred tax adjustments     (1,042,689)  
Excess value of common stock issued to settle liabilities     265,591
Changes in operating assets and liabilities:        
Accounts receivable     (5,646,523)
Contract assets     (5,641,421)
Prepaid expenses and other current assets     (282,650) (6,500)
Other receivable, related party     (9,431)
Due to / from related party     163,922  
Accounts payable     3,882,906 48,343
Accounts payable, related party     5,645,743 144,000
Accrued expenses and other current liabilities     841,566
Contract liabilities     84,806
Deferred tax liability     (65,662)
Operating lease liabilities, net     (11,817)
Net cash used in operating activities     (1,487,560) (1,653,959)
Cash flows from investing activities:        
Cash and restricted cash acquired from business combinations     1,391,391
Purchase of property, plant and equipment     (40,399)
Software development capitalization     (160,371)
Net cash used in investing activities     1,190,621
Cash flows from financing activities:        
Short-term advances, related party     596,199
Repayment of loan     (915)
Accounts receivable financing facility     331,432
Proceeds from sale of common stock     1,834,970 1,164,995
Net cash provided by financing activities     2,165,487 1,761,194
Effect of exchange rate changes on cash and cash equivalents     132,551  
Net change in cash and cash equivalents     2,001,099 107,235
Cash and cash equivalents and restricted cash at beginning of period 2,108,574 107,475 107,475 240
Cash and cash equivalents and restricted cash at end of period     2,108,574 107,475
Reconciliation of cash and restricted cash:        
Cash at beginning of period 2,087,400 107,475 107,475 240
Restricted cash at beginning of period 21,174
Cash and restricted cash at beginning of period $ 2,108,574 $ 107,475 107,475 240
Cash at end of period     2,087,400 107,475
Restricted cash at end of period     21,174
Cash and restricted cash at end of period     2,108,574 107,475
Supplemental disclosure of cash flow information:        
Cash paid for income taxes    
Cash paid for interest     5,771
Supplemental disclosure of non-cash operating activities:        
Issuances of common stock for consulting and marketing services - prepaid expense     4,427,500
Non-cash investing and financing activities:        
Purchase of intangible assets in exchange of issuance of common stock     19,710,000
Dividend payable to former owner of 42 arising from measurement year adjustment to goodwill     690,870
Contingent consideration liability recognized with business combination     38,225,750
Issuance of common stock pursuant to business combination     12,880,000
Common stock to be issued pursuant to business combination     3,407,250
Settlement of related party liabilities     675,700
Issuance of common stock in settlement of liabilities     10,000 88,100
Deferred tax adjustment to goodwill     $ 5,506,542